OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
📰 Original Source
Read Full Article on OpenAI News →
This article was originally published on OpenAI News. Click below to read the complete article.